Group 1 - The article discusses the significant opportunities in the green economy as the world seeks to reduce carbon emissions, highlighting a market-beating model portfolio and actionable research on undercovered stocks [1] - British American Tobacco (BAT) is mentioned, with previous valuations indicating approximately 12% price upside for 2025, suggesting potential for a larger increase amid current uncertainties [2] - The investing group Green Growth Giants, led by a macroeconomist with over 20 years of experience, focuses on generational opportunities in the green economy, providing deeper insights into this sector [2]

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.Zacks Premium also includes the Zacks Style Scores. What are the Zacks Style Scores? The Zacks Style Sc ...

Core Insights - Philip Morris International Inc. (PM) has seen a stock increase of 50.1% year to date, outperforming the Zacks Tobacco industry's 38.8% rise and the 7% growth of the Zacks Consumer Staples sector, while the S&P 500 has only increased by 0.9% [1][2][9] Performance Comparison - PM has outperformed competitors such as Altria Group, British American Tobacco, and Turning Point Brands, which have seen returns of 13.4%, 27.1%, and 24.7% respectively year to date [2] Factors Behind Growth - The surge in PM's stock is attributed to premium pricing in traditional tobacco, rapid expansion in smoke-free offerings, and tight cost controls [5] - As of June 4, 2025, PM's stock closed at $180.66, just 1.8% below its 52-week high, indicating potential for further growth [6] - PM's stock is trading above both its 50-day and 200-day moving averages, reflecting sustained upward momentum and investor confidence [7] Smoke-Free Business Expansion - Smoke-free net revenues increased by 20.4% in Q1 2025, driven by the expansion of IQOS, ZYN, and VEEV [9][10] - IQOS, PM's flagship product, saw a 9.4% growth in HTU-adjusted IMS, particularly in Japan and Europe, while ZYN shipments surged 53% to 202 million cans [11][12] - PM is now active in 95 markets with smoke-free offerings, confirming the effectiveness of its multi-category strategy [12] Traditional Tobacco Performance - PM's combustible tobacco business remains resilient, with flat reported net revenues but a 3.8% increase on an organic basis in Q1 2025 [13] - The company's global brand portfolio, led by Marlboro, gained market share, increasing PM's total cigarette category share by 0.4 percentage points to 24.8% [13] Financial Outlook - PM expects total volume growth of 2% in 2025, marking its fifth consecutive year of positive volume growth, with smoke-free products projected to grow by 12-14% [14] - Management forecasts net revenue growth of 6-8% on an organic basis, with adjusted EPS for 2025 expected to be between $7.36 and $7.49, indicating 12-14% growth from the previous year [15] Earnings Estimates - The Zacks Consensus Estimate for PM's 2025 earnings suggests a year-over-year growth of 13.7%, with the same for 2026 indicating an 11.7% increase [18] - For Q2 2025, adjusted EPS is projected to be between $1.80 and $1.85, reflecting year-over-year growth [17] Valuation Insights - PM is currently trading at a forward P/E ratio of 23.04, significantly above the tobacco industry average of 15.49, indicating strong investor confidence in its growth trajectory [20] - Compared to peers, PM commands a premium valuation, reflecting a market perception of it as a growth-oriented company within the tobacco industry [21][22] Conclusion - PM is positioned as a leader in the shift toward reduced-risk products, with strong pricing power, accelerating smoke-free growth, and consistent earnings momentum, making it an attractive long-term investment opportunity [24][25]

Core Insights - Altria Group, Inc. is progressing towards a smoke-free future, with its oral nicotine pouch brand on! being a significant growth driver as consumer preferences shift towards reduced-risk products [1][5] Group 1: Product Performance - In Q1 2025, on! shipment volume increased by 18% year over year, exceeding 39 million cans, and its retail market share in the oral tobacco category rose to 8.8%, a 1.8 share point increase [2][10] - Within the nicotine pouch segment, on! achieved a market share of 17.9%, gaining 0.5 points, indicating strong brand equity and consumer loyalty despite higher retail pricing [2][10] Group 2: Financial Performance - Altria's Oral Tobacco Products segment generated revenues of $654 million in Q1 2025, reflecting a 0.5% year-over-year increase, primarily driven by pricing strength [3][10] - The company's forward price-to-earnings ratio stands at 10.87X, which is below the industry average of 15.49X [12] Group 3: Strategic Initiatives - Altria has initiated the "Optimize & Accelerate" program, aiming for at least $600 million in cost savings over five years, focusing on enhancing efficiency and reinvesting in smoke-free innovations [4] - The company is positioning itself to lead in the smoke-free nicotine market, with on! becoming a cornerstone of its growth strategy [5] Group 4: Competitive Landscape - Key competitors in the smoke-free category include Philip Morris International and British American Tobacco, both of which are also shifting towards reduced-risk products [6][7][8] - Philip Morris reported that smoke-free products contributed 44% of its gross profit in Q1 2025, with significant growth in ZYN and VEEV shipments [7] - British American Tobacco aims to reach 50 million consumers by 2030, with its smokeless user base at 29.1 million in 2024 [8] Group 5: Earnings Estimates - The Zacks Consensus Estimate for Altria's 2025 earnings indicates a year-over-year growth of 4.5%, with 2026 estimates suggesting a 3.5% increase [13]

Core Viewpoint - Imperial Tobacco Group PLC (IMBBY) has received a Zacks Rank 2 (Buy) upgrade, indicating a positive outlook on its earnings estimates, which is a significant factor influencing stock prices [1][4]. Earnings Estimates and Revisions - The Zacks Consensus Estimate for Imperial Tobacco Group for the fiscal year ending September 2025 is projected at $4.17 per share, reflecting an 11.5% increase from the previous year's reported figure [9]. - Over the past three months, the Zacks Consensus Estimate for the company has risen by 2%, indicating a trend of increasing earnings estimates [9]. Zacks Rating System - The Zacks rating system is based on changes in a company's earnings picture, which is a critical determinant of stock price movements [2][3]. - The system classifies stocks into five groups, with Zacks Rank 1 (Strong Buy) to Zacks Rank 5 (Strong Sell), and has shown a strong track record, with Zacks Rank 1 stocks averaging a +25% annual return since 1988 [8]. Market Implications - The upgrade to Zacks Rank 2 places Imperial Tobacco Group in the top 20% of Zacks-covered stocks, suggesting a strong potential for market-beating returns in the near term due to favorable earnings estimate revisions [11]. - Rising earnings estimates and the corresponding rating upgrade indicate an improvement in the company's underlying business, which is expected to drive stock price appreciation [6].

Group 1 - The company is increasing its annual subscription price by 25% starting June 10th, encouraging current subscribers to lock in legacy pricing [1] - The focus of the investment group is on high return on equity and high free cash flow stocks that have a proven track record of compounding earnings at rates higher than the market [1] - The investment group provides in-depth research with 2-4 new high-quality investment ideas each month, which have historically earned returns well above benchmark levels [1] Group 2 - Thomas Lott leads the investment group Cash Flow Compounders, aiming to identify the best companies globally that are trading at attractive valuations [2] - The investment strategy is influenced by Graham and Dodd/Buffett style investing, focusing on high-quality equities at appealing valuations [2] - Thomas Lott has over 30 years of experience in the financial industry, starting as a portfolio manager at a hedge fund in 2003, and holds an MBA from Northwestern's Kellogg School of Management [2]

Core Insights - Philip Morris International Inc. (PM) is undergoing a significant transformation towards reduced-risk products, with smoke-free products contributing to 44% of total gross profit in Q1 2025 [1][9]. Group 1: Business Transformation - The company's multi-category strategy includes products like IQOS, ZYN, and VEEV, with IQOS showing a 9.4% HTU-adjusted IMS growth in Q1 despite regulatory challenges in Europe [2]. - ZYN's shipments in the U.S. surged by 53% year-over-year, reaching 202 million cans, prompting an increase in the full-year shipment forecast to 800-840 million cans [2][9]. - VEEV's shipment volumes more than doubled in the quarter, benefiting from expanded distribution in Europe [3]. Group 2: Financial Performance - The smoke-free segment experienced a 20.4% increase in net revenues and a 33.1% rise in gross profit, with gross margins exceeding 70% [3][9]. - PM's smoke-free products are now available in 95 markets, with nearly 38.6 million adult users globally [4][9]. Group 3: Competitive Landscape - Altria Group is focusing on building a smoke-free portfolio, with its on! nicotine pouch seeing an 18% year-over-year growth in shipments [6]. - British American Tobacco aims to reach 50 million consumers of smokeless products by 2030, with New Category revenues rising 2.5% in 2024 [7]. Group 4: Stock Performance and Valuation - PM's shares have increased by 51.4% year-to-date, outperforming the industry's growth of 38.5% [8]. - The company trades at a forward price-to-earnings ratio of 23.27X, above the industry's average of 15.46X [11]. - The Zacks Consensus Estimate for PM's 2025 earnings indicates a year-over-year growth of 13.7% [12].

Financial Performance & Guidance - The company is targeting another year of best-in-class top and bottom-line growth, driven by volumes, pricing, mix, and efficiencies while investing for growth[3] - The company confirms full-year adjusted diluted EPS guidance of $7.36 to $7.49, representing 12% to 14% growth in USD[3] - Excluding currency impacts, the adjusted diluted EPS growth is expected to be 10.5% to 12.5%[3] - Reported diluted EPS forecast for 2025 is $7.01 to $7.14, compared to $4.52 in 2024[6] - Adjusted diluted EPS for 2025 is projected to be $7.36 to $7.49, compared to $6.57 in 2024, a growth of 12% to 14%[6] Business Strategy & Outlook - The company is increasingly deploying a multi-category strategy across markets with premium smoke-free alternatives like IQOS, ZYN, and VEEV[3] - The company continues to expect low single-digit combustible volume declines for 2025[3] - The company is well-positioned to navigate external volatility and is on track for strong H1 and FY performance[3] Risk Factors - The company's business is subject to various risks, including excise tax increases, marketing and regulatory restrictions, health concerns, litigation, and intense competition[2] - Global and individual country economic, regulatory, and political developments, natural disasters, and conflicts, including the impact of Russia's invasion of Ukraine, also pose risks[2] - Unfavorable currency exchange rates, adverse changes in corporate tax laws, trade tariffs, and the cost and availability of raw materials are additional risk factors[2]

Company Overview - Philip Morris International is on track for another year of strong growth in revenue, operating income, and adjusted EPS before foreign exchange impacts, primarily driven by the robust growth of its smoke-free portfolio [5]. Performance Highlights - The company reported nearly a 10% adjusted in-market sales progression in Q1, with Japan showing close to 10% growth and Europe experiencing a bit above 7% growth despite challenges [6]. - The flavor ban in Europe is expected to impact sales by around 1 billion sticks in 2025, but the company anticipates a gradual recovery in the European market as it progresses through 2025 [6].

Core Insights - British American Tobacco (BAT) expects full year revenue growth of 1% to 2% and adjusted profit from operations growth of 1.5% to 2.5% for 2025, slightly ahead of previous guidance [4]. Group 1 - The company anticipates a return to revenue and profit growth in the U.S. for the first half of 2025 [4].